Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
Rubio IT, Wyld L, Marotti L, Athanasiou A, Regitnig P, Catanuto G, Schoones JW, Zambon M, Camps J, Santini D, Dietz J, Sardanelli F, Varga Z, Smidt M, Sharma N, Shaaban AM, Gilbert F. Rubio IT, et al. Among authors: regitnig p. Eur J Surg Oncol. 2024 Jan;50(1):107292. doi: 10.1016/j.ejso.2023.107292. Epub 2023 Nov 27. Eur J Surg Oncol. 2024. PMID: 38061151 Free article.
EUSOMA quality indicators for non-metastatic breast cancer: An update.
Rubio IT, Marotti L, Biganzoli L, Aristei C, Athanasiou A, Campbell C, Cardoso F, Cardoso MJ, Coles CE, Eicher M, Harbeck N, Karakatsanis A, Offersen BV, Pijnappel R, Ponti A, Regitnig P, Santini D, Sardanelli F, Spanic T, Varga Z, Vrancken Peeters MJTFD, Wengström Y, Wyld L, Curigliano G. Rubio IT, et al. Among authors: regitnig p. Eur J Cancer. 2024 Feb;198:113500. doi: 10.1016/j.ejca.2023.113500. Epub 2023 Dec 26. Eur J Cancer. 2024. PMID: 38199146
Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292].
Rubio IT, Wyld L, Marotti L, Athanasiou A, Regitnig P, Catanuto G, Schoones JW, Zambon M, Camps J, Santini D, Dietz J, Sardanelli F, Varga Z, Smidt M, Sharma N, Shaaban AM, Gilbert F. Rubio IT, et al. Among authors: regitnig p. Eur J Surg Oncol. 2024 Mar;50(3):107943. doi: 10.1016/j.ejso.2023.107943. Epub 2024 Jan 20. Eur J Surg Oncol. 2024. PMID: 38246851 Free article. No abstract available.
Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.
Huemer F, Weiss L, Regitnig P, Winder T, Schmitt CA, Thaler J, Wöll E, Greil R. Huemer F, et al. Among authors: regitnig p. ESMO Open. 2024 Apr;9(4):102973. doi: 10.1016/j.esmoop.2024.102973. Epub 2024 Mar 19. ESMO Open. 2024. PMID: 38507896 Free PMC article. No abstract available.
Biomechanical characterization of the passive porcine stomach.
Holzer CS, Pukaluk A, Viertler C, Regitnig P, Caulk AW, Eschbach M, Contini EM, Holzapfel GA. Holzer CS, et al. Among authors: regitnig p. Acta Biomater. 2024 Jan 1;173:167-183. doi: 10.1016/j.actbio.2023.11.008. Epub 2023 Nov 19. Acta Biomater. 2024. PMID: 37984627 Free article.
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z. Elfgen C, et al. Among authors: regitnig p. Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17. Virchows Arch. 2023. PMID: 37330436 Free PMC article. Review.
Explainability and causability in digital pathology.
Plass M, Kargl M, Kiehl TR, Regitnig P, Geißler C, Evans T, Zerbe N, Carvalho R, Holzinger A, Müller H. Plass M, et al. Among authors: regitnig p. J Pathol Clin Res. 2023 Jul;9(4):251-260. doi: 10.1002/cjp2.322. Epub 2023 Apr 12. J Pathol Clin Res. 2023. PMID: 37045794 Free PMC article. Review.
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
Cserni B, Kilmartin D, O'Loughlin M, Andreu X, Bagó-Horváth Z, Bianchi S, Chmielik E, Figueiredo P, Floris G, Foschini MP, Kovács A, Heikkilä P, Kulka J, Laenkholm AV, Liepniece-Karele I, Marchiò C, Provenzano E, Regitnig P, Reiner A, Ryška A, Sapino A, Stovgaard ES, Quinn C, Zolota V, Webber M, Glynn SA, Bori R, Csörgő E, Oláh-Németh O, Pancsa T, Sejben A, Sejben I, Vörös A, Zombori T, Nyári T, Callagy G, Cserni G. Cserni B, et al. Among authors: regitnig p. Cancers (Basel). 2023 Feb 14;15(4):1199. doi: 10.3390/cancers15041199. Cancers (Basel). 2023. PMID: 36831541 Free PMC article.
110 results